Spyryx Biosciences

Business Area(s): 

Spyryx Biosciences is pioneering the use of inhaled peptides to treat severe pulmonary diseases where mucus accumulation and obstructions are key to disease progression. Spyryx's compounds have a novel mechanism of action that removes epithelial sodium channels from the airway surface with the therapeutic goal of increasing airway hydration and mucus clearance to enhance lung performance.

Durham NC
United States